Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture
Aartjan J W te Velthuis, Sjoerd H E van den Worm, Amy C Sims, Ralph S Baric, Eric J Snijder, Martijn J van Hemert, Aartjan J W te Velthuis, Sjoerd H E van den Worm, Amy C Sims, Ralph S Baric, Eric J Snijder, Martijn J van Hemert
Abstract
Increasing the intracellular Zn(2+) concentration with zinc-ionophores like pyrithione (PT) can efficiently impair the replication of a variety of RNA viruses, including poliovirus and influenza virus. For some viruses this effect has been attributed to interference with viral polyprotein processing. In this study we demonstrate that the combination of Zn(2+) and PT at low concentrations (2 µM Zn(2+) and 2 µM PT) inhibits the replication of SARS-coronavirus (SARS-CoV) and equine arteritis virus (EAV) in cell culture. The RNA synthesis of these two distantly related nidoviruses is catalyzed by an RNA-dependent RNA polymerase (RdRp), which is the core enzyme of their multiprotein replication and transcription complex (RTC). Using an activity assay for RTCs isolated from cells infected with SARS-CoV or EAV--thus eliminating the need for PT to transport Zn(2+) across the plasma membrane--we show that Zn(2+) efficiently inhibits the RNA-synthesizing activity of the RTCs of both viruses. Enzymatic studies using recombinant RdRps (SARS-CoV nsp12 and EAV nsp9) purified from E. coli subsequently revealed that Zn(2+) directly inhibited the in vitro activity of both nidovirus polymerases. More specifically, Zn(2+) was found to block the initiation step of EAV RNA synthesis, whereas in the case of the SARS-CoV RdRp elongation was inhibited and template binding reduced. By chelating Zn(2+) with MgEDTA, the inhibitory effect of the divalent cation could be reversed, which provides a novel experimental tool for in vitro studies of the molecular details of nidovirus replication and transcription.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Lazarczyk M, Favre M. Role of Zn2+ ions in host-virus interactions. J Virol. 2008;82:11486–11494.
- Frederickson CJ, Koh JY, Bush AI. Neurobiology of zinc in health and disease. Nat Rev Neurosci. 2005;6:449–462.
- Alirezaei M, Nairn AC, Glowinski J, Premont J, Marin P. Zinc inhibits protein synthesis in neurons: potential rol of phosphorylation of translation initiation factor-2a. J Biol Chem. 1999;274:32433–32438.
- Uchide N, Ohyama K, Bessho T, Yuan B, Yamakawa T. Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Res. 2002;56:207–217.
- Suara RO, Crowe JEJ. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother. 2004;48:783–790.
- Gaudernak E, Seipelt J, Triendl A, Grassauer A, Kuechler E. Antiviral Effects of Pyrrolidine Dithiocarbamate on Human Rhinoviruses. J Virol. 2002;76:6004–6015.
- Si X, McManus BM, Zhang J, Yuan J, Cheung C, et al. Pyrrolidine Dithiocarbamate Reduces Coxsackievirus B3 Replication through Inhibition of the Ubiquitin-Proteasome Pathway. J Virol. 2005;79:8014–8023.
- Korant BD, Kauer JC, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature. 1974;248:588–590.
- Polatnick J, Bachrach HL. Effect of zinc and other chemical agents on foot-and-mouth-disease virus replication. Antimicrob Agents Chemother. 1978;13:731–734.
- Lanke K, Krenn BM, Melchers WJG, Seipelt J, van Kuppeveld FJM. PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. J Gen Virol. 2007;88:1206–1217.
- Krenn BM, Gaudernak E, Holzer B, Lanke K, Van Kuppeveld FJM, et al. Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus Infections. J Virol. 2009;83:58–64.
- Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin [(2-methyl-8-p-toluenesulphonamide-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J. 1993;296:403–408.
- Baum EZ, Bebernitz GA, Palant O, Mueller T, Plotch SJ. Purification, properties, and mutagenesis of poliovirus 3C protease. Virology. 1991;165:140–150.
- Cordingley MG, Register RB, Callahan PL, Garsky VM, Colonno RJ. Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol. 1989;63:5037–5045.
- Ferrari E, Wright-Minogue J, Fang JW, Baroudy BM, Lau JY, et al. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol. 1999;73:1649–1654.
- Hung M, Gibbs CS, Tsiang M. Biochemical characterization of rhinovirus RNA-dependent RNA polymerase. Antiviral Res. 2002;56:99–114.
- Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Micro. 2009;7:439–450.
- Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006;117:17–37.
- Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 2003;331:991–1004.
- Pasternak AO, Spaan WJ, Snijder EJ. Nidovirus transcription: how to make sense…? J Gen Virol. 2006;80:1403–1421.
- Sawicki SG, Sawicki DL, Siddell SG. A Contemporary View of Coronavirus Transcription. J Virol. 2007;81:20–29.
- Butterworth BE, Korant BD. Characterization of the large picornaviral polypeptides produced in the presence of zinc ion. J Virol. 1974;14:282–291.
- Denison MR, Perlman S. Translation and processing of mouse hepatitis virus virion RNA in a cell-free system. J Virol. 1986;60:12–18.
- Denison MR, Zoltick PW, Hughes SA, Giangreco B, Olson AL, et al. Intracellular processing of the N-terminal ORF 1a proteins of the coronavirus MHV-A59 requires multiple proteolytic events. Virology. 1992;189:274–284.
- van Hemert MJ, de Wilde AH, Gorbalenya AE, Snijder EJ. The in Vitro RNA Synthesizing Activity of the Isolated Arterivirus Replication/Transcription Complex Is Dependent on a Host Factor. J Biol Chem. 2008;283:16525–16536.
- van Hemert MJ, van den Worm SHE, Knoops K, Mommaas AM, Gorbalenya AE, et al. SARS-Coronavirus Replication/Transcription Complexes Are Membrane-Protected and Need a Host Factor for Activity In Vitro. PLoS Pathog. 2008;4:e1000054.
- te Velthuis AJ, Arnold JJ, Cameron CE, van den Worm SH, Snijder EJ. The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent. Nucleic Acids Res. 2009;38:203–214.
- Beerens N, Selisko B, Ricagno S, Imbert I, van der Zanden L, et al. De Novo Initiation of RNA Synthesis by the Arterivirus RNA-Dependent RNA Polymerase. J Virol. 2007;81:8384–8395.
- van den Born E, Posthuma CC, Knoops K, Snijder EJ. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J Gen Virol. 2007;88:1196–1205.
- Sims AC, Burkett SE, Yount B, Pickles RJ. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Virus Res. 2008;133:33–44.
- Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, et al. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res. 2003;31:7117–7130.
- Zhai Y, Sun F, Li X, Pang H, Xu X, et al. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nat Struct Mol Biol. 2005;12:980–986.
- Stockman LJ, Bellamy R, Garner P. SARS: Systematic Review of Treatment Effects. PLoS Med. 2006;3:e343.
- Thompson A, Patel K, Tillman H, McHutchison JG. Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges. J Hepatol. 2009;50:184–194.
- De Clercq E. Antivirals and antiviral strategies. Nat Rev Microbiol. 2004;2:704–720.
- Thompson AJV, McHutchison JG. Antiviral resistance and specifically targeted therapy for HCV (STAT-C). J Viral Hepat. 2009;16:377–387.
- Yang W, Lee JY, Nowotny M. Making and Breaking Nucleic Acids: Two-Mg2+-Ion Catalysis and Substrate Specificity. Mol Cell. 2006;22:5–13.
- Castro C, Smidansky E, Maksimchuk KR, Arnold JJ, Korneeva VS, et al. Two proton transfers in the transition state for nucleotidyl transfer catalyzed by RNA- and DNA-dependent RNA and DNA polymerases. Proc Natl Acad Sci USA. 2007;104:4267–4272.
- Arnold JJ, Ghosh SK, Cameron CE. Poliovirus RNA-dependent RNA Polymerase (3Dpol). Divalent cation modulation of primer, template and nucleotide selection. J Biol Chem. 1999;274:37060–37069.
- Iuchi S. Three classes of C2H2 zinc finger proteins. Cell Mol Life Sci. 2001;58:625–635.
- Gomis-Ruth XF. Catalytic domain architecture of metzincin metalloproteases. J Biol Chem. 2009;284:15353–15357.
- Yap TL, Xu T, Chen Y-L, Malet H, Egloff M-P, et al. Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution. J Virol. 2007;81:4753–4765.
- Winek CL, Buehler EV. Intravenous toxicity of zinc pyridinethione and several zinc salts. Toxicol Appl Pharmacol. 1966;9:296–273.
- Snyder DR, de Jesus CP, Towfighi J, Jacoby RO, Wedig JH. Neurological, microscopic and enzyme-histochemical assessment of zinc pyrithione toxicity. Food Cosmet Toxicol. 1979;17:651–660.
- Magda D, Lecane P, Wang Z, Hu W, Thiemann P, et al. Synthesis and anticancer properties of water-soluble zinc ionophores. Cancer Res. 2008;68:5318–5325.
- Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJM, van der Meulen J, et al. Ultrastructure and Origin of Membrane Vesicles Associated with the Severe Acute Respiratory Syndrome Coronavirus Replication Complex. J Virol. 2006;80:5927–5940.
- Studier F. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif. 2005;41:207–234.
Source: PubMed